StockData

Heartflow vs Kestra Medical Technologies

HTFL and KMTS side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How HTFL and KMTS compare

Heartflow is the larger company, worth 2.7 times as much as Kestra Medical Technologies ($5.1B against $1.9B).

Kestra Medical Technologies grew revenue faster over the last twelve months (60.7% versus 42.8% for Heartflow).

Heartflow keeps more of each dollar of sales as profit, with a net margin of −55.8% compared with −140% at Kestra Medical Technologies.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricHTFLKMTS
Size and price
Market cap$5.1B$1.9B
Share price$59.10$31.63
Change, 1 year74.7%19.7%
Beta (5Y)1.961.27
Employees843443
StockData Score
Total score55
Valuation score00
Growth score33
Performance score00
Health score22
Dividend score00
Valuation
P/S24.2×17.7× (better)
P/B18.4×–
FCF yield−1.2% (better)−6.5%
Fair value$8.61–
Margin of safety−586%–
Growth
Revenue growth (TTM)42.8%60.7% (better)
Profitability
Gross margin80.1% (better)53.9%
Operating margin−37.8% (better)−134%
Net margin−55.8% (better)−140%
FCF margin−27.9% (better)−115%
Financial health
Interest coverage−23.2×−19.0× (better)
Current ratio5.08 (better)4.69
Altman Z-score43.51 (better)5.80
Piotroski F-score6 (better)4
Dividends and buybacks
Shareholder yield0.00%0.00%
Ownership
Held by institutions86.0%98.6%
Held by insiders58.7%44.0%
Insider net buying, 12 months−$143M−$15.3M (better)
Short interest, % of float15.9%12.3%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.